logo

Shariah compliance overview

Halal

Genmab A/S (GNMSF) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Genmab A/S

Genmab A/S, founded in 1999 and based in Copenhagen, Denmark, is a biopharmaceutical firm focused on developing antibody-based therapeutics to treat cancer and a range of other diseases.

Genmab A/S (GNMSF) operates in the Healthcare sector, in the Biotechnology industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.58% (limit 5%), interest-bearing debt is 7.69% (limit 30%) and interest-bearing securities and assets are 2.43% (limit 30%).

If you hold GNMSF, give 3.58% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
3.58%Limit 5%Pass
Interest-bearing debt
7.69%Limit 30%Pass
Interest-bearing securities and assets
2.43%Limit 30%Pass
Dividend purification
3.58%Share of dividends to give to charityPurification calculator

Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Genmab A/S (GNMSF). Current Akinda screening label: Halal.